ArticlemedRxiv : the preprint server for health sciences2026
Minimal Residual Disease via circulating tumor DNA Predicts Exceptional Response in HER2-Positive Metastatic Breast Cancer.
Stefania Morganti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.